With support from a $2.5 million NIH grant, UB chemist David Heppner is trying to answer key questions about the time-consuming and costly drug discovery process.
As the use of Ritalin rises among those without ADHD symptoms, a CRIA study warns that such use may cause irreversible structural changes in the brain.